Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2009 - 2026)

Edwards Lifesciences' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 29.38% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $56.9 million (up 169.31% YoY), while the FY2025 annual figure was $62.1 million, up 8.0% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $12.5 million, up from $7.9 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $566.1 million in Q2 2022, with the low at -$481.6 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2022), against an average of $38.2 million.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments jumped 1515.25% in 2022, then sank 200.76% in 2024.
• Edwards Lifesciences' Change in Acquisitions & Divestments stood at -$341.6 million in 2022, then fell by 13.88% to -$389.0 million in 2023, then retreated by 23.8% to -$481.6 million in 2024, then jumped by 101.64% to $7.9 million in 2025, then surged by 58.23% to $12.5 million in 2026.
• Business Quant data shows EW's Change in Acquisitions & Divestments at $12.5 million in Q1 2026, $7.9 million in Q4 2025, and $22.2 million in Q3 2025.